InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
T+90 hit rate
71%
T+90 mean return
+13.0%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Brown Victoria L., Executive. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 8 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €115k. Activity tracked since 26 October 2021. The latest transaction was filed on 20 January 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations8 total
1,412 shares@ US$52.0590.0% of flowCommon StockSEC:0001127602-23-002109:0
130 shares@ US$58.4110.0% of flowCommon StockSEC:0000899243-22-034414:0
2,698 shares@ US$45.000.0022% mcap73.8% of flowCommon StockSEC:0001127602-22-017990:0
82 shares@ US$49.280.0001% mcap2.4% of flowCommon StockSEC:0001127602-22-010532:0
175 shares@ US$47.120.0001% mcap4.6% of flowCommon StockSEC:0001127602-22-004777:0
434 shares@ US$38.590.0003% mcap9.6% of flowCommon StockSEC:0001127602-22-002817:0
17,466 shares0Common StockSEC:0001127602-22-002058:0
882 shares0Common StockSEC:0001127602-21-027695:0
8 of 8 declarations
About Brown Victoria L.
Victoria L. Brown is responsible for the program team at Apellis Pharmaceuticals, Inc. While her specific role is not detailed, she contributes to the management and strategy of the organization. Her expertise is essential in supporting the financial and operational goals of the company.
